Kaposi sarcoma (KS) is an angioproliferative disease that is caused by human herpesvirus 8. The epidemic form of KS is associated with acquired immunodeficiency syndrome (AIDS) and is common in HIV-positive patients with CD4 counts less than 200 cells/mm. We present the case of a 63-year-old man with well-controlled HIV and normal CD4 count developing atypical nasal KS associated with intranasal steroid use.
TrattnerAHodakEDavidM, et al.The appearance of Kaposi sarcoma during corticosteroid therapy. Cancer1993; 72(5): 1779–1783.
2.
TounougaDNKouotouEANansseuJR, et al.Epidemiological and clinical patterns of Kaposi sarcoma: a 16-year retrospective cross-sectional study from Yaoundé, Cameroon. Dermatology2018; 234(5–6): 198–204.
3.
GallafentJHBuskinSEDe TurkPB, et al.Profile of patients with Kaposi’s sarcoma in the era of highly active antiretroviral therapy. J Clin Oncol2005; 23(6): 1253–1260.
4.
MaurerTPonteMLeslieK. HIV-associated Kaposi’s sarcoma with a high CD4 count and a low viral load. N Engl J Med2007; 357(13): 1352–1353.
5.
SoonGSTPeterssonFThongMKT, et al.Primary nasopharyngeal Kaposi sarcoma as index diagnosis of AIDS in a previously healthy man. Head Neck Pathol2019; 13(4): 664–667.
6.
MilesSAMartínez-MazaORezaiA, et al.Oncostatin M as a potent mitogen for AIDS-Kaposi’s sarcoma-derived cells. Science1992; 255(5050): 1432–1434.
7.
GuoWXAntaklyT. AIDS-related Kaposi’s sarcoma: evidence for direct stimulatory effect of glucocorticoid on cell proliferation. Am J Pathol1995; 146(3): 727–734.
8.
TyrosGPotouridouITsaraklisA, et al.A generalized Kaposi’s sarcoma after chronic and extensive topical corticosteroid use. Eur J Dermatol2014; 24(1): 111–112.
